Clinical Trial Update: Abraxane and Alimta in Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial of Abraxane and Alimta in advanced solid tumors terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Lung Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Alimta (pemetrexed)

Snippet

Sponsor: University of California, Davis | Conditions: Breast Cancer, Lung Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2017-03-08